{
  "id": "54d776453706e89528000018",
  "type": "summary",
  "question": "What was the aim of the HAMLET clinical trial?",
  "ideal_answer": "The aim of the HAMLET (Hemicraniectomy After Middle Cerebral Artery Infarction With Life-Threatening Edema Trial) clinical trial was to compare the efficacy of decompressive surgery to improve functional outcome with that of conservative treatment in patients with space-occupying supratentorial infarction.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/17400593",
    "http://www.ncbi.nlm.nih.gov/pubmed/16965617",
    "http://www.ncbi.nlm.nih.gov/pubmed/19269254",
    "http://www.ncbi.nlm.nih.gov/pubmed/23868265",
    "http://www.ncbi.nlm.nih.gov/pubmed/14723030",
    "http://www.ncbi.nlm.nih.gov/pubmed/17303527",
    "http://www.ncbi.nlm.nih.gov/pubmed/23943217"
  ],
  "snippets": [
    {
      "text": "METHODS: We assessed clinical outcomes, costs, and cost-effectiveness for the first 3 years in patients who were randomized to surgical decompression or best medical treatment within 48 hours after symptom onset in the Hemicraniectomy After Middle Cerebral Artery Infarction With Life-Threatening Edema Trial (HAMLET). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23943217",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Surgical decompression for space-occupying cerebral infarction: outcomes at 3 years in the randomized HAMLET trial.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23868265",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "METHODS: Patients with space-occupying hemispheric infarction, who were enrolled in the Hemicraniectomy After Middle cerebral artery infarction with Life-threatening Edema Trial within 4 days after stroke onset, were followed up at 3 years. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23868265",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We studied differences in recall of information and in appreciation of the informed consent procedure between representatives included in the Hemicraniectomy After Middle cerebral artery infarction with Life-threatening Edema Trial (HAMLET) and representatives of patients participating in the randomised trial of Paracetamol (Acetaminophen) In Stroke (PAIS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17400593",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Hemicraniectomy after middle cerebral artery infarction with life-threatening Edema trial (HAMLET).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16965617",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "This study is designed to compare the efficacy of decompressive surgery to improve functional outcome with that of conservative treatment in patients with space-occupying supratentorial infarction",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16965617",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The 'Hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial' (HAMLET) is a newly-conceived randomised multi-centre clinical trial that compares the efficacy of decompressive surgery to improve functional outcome with that of conservative treatment in patients with space-occupying supratentorial infarction.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14723030",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The aim of HAMLET was to assess the effect of decompressive surgery within 4 days of the onset of symptoms in patients with space-occupying hemispheric infarction.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19269254",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}